Co-variates | HR | CI 95% | P-value |
---|---|---|---|
Sex f/m | 0.314/f | 0.177, 0.557 | 0.001 |
Age at onset of RA | 1.060/yr | 1.035, 1.086 | <0.001 |
Diabetes mellitus | 2.893/+ | 1.297, 6.452 | <0.01 |
Hypertension, treated | 4.066/+ | 2.308, 7.162 | <0.001 |
BP, syst | 1.015/mmHg | 1.003, 1.026 | <0.05 |
BP, diast | 1.033/mmHg | 1.003, 1.063 | <0.05 |
S-HDL-chol | 0.318/mmolL-1 | 0.090, 1.123 | = 0.075 |
S-Triglycerides | 1.919/mmolL-1 | 1.461, 2.521 | <0.001 |
Statin treatment | 2.237/+ | 0.950, 5.270 | = 0.065 |
Previous CVE | 5.912/+ | 3.210, 10.891 | <0.001 |
AUC DAS28 (6 mo) | 1.063 | 1.021, 1.106 | <0.01 |
AUC DAS281 | 1.025 | 1.010, 1.040 | <0.01 |
Extra-articular disease1 | 3.343/+ | 1.421, 7.867 | <0.01 |
Corticosteroids at/before inclusion | 1.030/mo | 1.004, 1.056 | <0.05 |
Corticosteroids1 | 2.243/+ | 1.208, 4.164 | <0.05 |
DMARDs within 3 mo2 | 0.402/+ | 0.200, 0.808 | <0.05 |
DMARDs1 | 0.885/mo | 0.200, 0.808 | <0.001 |
COX-2-inhibitors1 | 2.392/+ | 1.206, 4.744 | <0.05 |